Sonia Kumari Shishodia

Sonia Kumari Shishodia

Auto-generated profile, based on publicly available information

Sonia Kumari Shishodia

University Institute of Biotechnology, Chandigarh University

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 February 2019 in Mycology
Verified
Journal Article
Open access
SSSonia Kumari Shishodia
Sonia Kumari Shishodia
STShraddha Tiwari
Shraddha Tiwari
JSJata Shankar
Jata Shankar
Aspergillus species contain pathogenic and opportunistic fungal pathogens which have the potential to cause mycosis (invasive aspergillosis) in humans. The existing antifungal drugs have limitation largely due to the development of drug-resistant isolates. To gain insight into the mechanism of action and antifungal drug resistance in Aspergillus species including biofilm formation, we have reviewed protein data of Aspergillus species during interaction with antifungals drugs (polynes, azoles and echinocandin) and phytochemicals (artemisinin, coumarin and quercetin). Our analyses provided a list of Aspergillus proteins (72 proteins) that were abundant during interaction with different antifungal agents. On the other hand, there are 26 proteins, expression level of which is affected by more than two antifungal agents, suggesting the more general response to the stress induced by the antifungal agents. Our analysis showed enzymes from cell wall remodelling, oxidative stress response and energy metabolism are the responsible factors for providing resistance against antifungal drugs in Aspergillus species and could be explored further in clinical isolates. Also, these findings have clinical importance since the effect of drug targeting different proteins can be potentiated by combination therapy. We have also discussed the opportunities ahead to study the functional role of proteins from environmental and clinical isolates of Aspergillus during its interaction with the antifungal drugs. Abbreviations: IPA: invasive pulmonary aspergillosis; IA: invasive aspergillosis; AmB: Amphotericin B; CAS: Caspofungin; VRC: Voriconazole; ITC: Itraconazole; POS: Posaconazole; ART: Artemisinin; QRT: Quercetin; CMR: Coumarin; MIC: minimal inhibitory concentration.

29 May 2018 in Frontiers in Cellular and Infection Microbiology
Verified
Journal Article
Open access
PDF file
JSJata Shankar
Jata Shankar
STShraddha Tiwari
Shraddha Tiwari
SSSonia K. Shishodia
Sonia K. Shishodia
MGManali Gangwar
Manali Gangwar
SHShanu Hoda
Shanu Hoda
PVPooja Vijayaraghavan
Pooja Vijayaraghavan
Aspergillus species are the major cause of health concern worldwide in immunocompromised individuals. Opportunistic Aspergilli cause invasive to allergic aspergillosis, whereas non-infectious Aspergilli have contributed to understand the biology of eukaryotic organisms and serve as a model organism. Morphotypes of Aspergilli such as conidia or mycelia/hyphae helped them to survive in favorable or unfavorable environmental conditions. These morphotypes contribute to virulence, pathogenicity and invasion into hosts by excreting proteins, enzymes or toxins. Morphological transition of Aspergillus species has been a critical step to infect host or to colonize on food products. Thus, we reviewed proteins from Aspergilli to understand the biological processes, biochemical, and cellular pathways that are involved in transition and morphogenesis. We majorly analyzed proteomic studies on A. fumigatus, A. flavus, A. terreus, and A. niger to gain insight into mechanisms involved in the transition from conidia to mycelia along with the role of secondary metabolites. Proteome analysis of morphotypes of Aspergilli provided information on key biological pathways required to exit conidial dormancy, consortia of virulent factors and mycotoxins during the transition. The application of proteomic approaches has uncovered the biological processes during development as well as intermediates of secondary metabolite biosynthesis pathway. We listed key proteins/ enzymes or toxins at different morphological types of Aspergillus that could be applicable in discovery of novel therapeutic targets or metabolite based diagnostic markers.

1 July 2020 in Journal of Proteomics
Verified
Journal Article
Closed access
SSSonia K. Shishodia
Sonia K. Shishodia
JSJata Shankar
Jata Shankar

13 January 2020 in Mycology
Verified
Journal Article
Open access
SSSonia K. Shishodia
Sonia K. Shishodia
STShraddha Tiwari
Shraddha Tiwari
SHShanu Hoda
Shanu Hoda
PVPooja Vijayaraghavan
Pooja Vijayaraghavan
JSJata Shankar
Jata Shankar
Aspergillus flavus exploits diverse mechanisms to survive during exposure to antifungal agents including morphogenesis. Germination of dormant conidia involves cascades of reactions integrated into the signalling pathway. This study documents the effect of phytochemical-quercetin on A. flavus during germination of conidia using scanning electron microscopy (SEM). Significant inhibition of conidial swelling of A. flavus in comparison to control was observed at 4 and 7 h Quantitative real-time PCR for genes from calcium signalling pathway and heat-shock proteins family showed up-regulation of heat shock (Hsp70 and Hsp90) and calcium signalling pathway genes (calcium-transporting ATPase and calmodulin) in response to quercetin at initial 4 h in comparison to control sample whereas up-regulation of Hsp70, calcineurin and transcription factor Crz1, were observed in both the treated samples. Gene encoding for calcium-kinase, cAMP, Rho-gdp, Plc and Pkc showed a constitutively higher level of expression in quercetin-treated sample in comparison to control at both time points. These data showed a clear response from genes encoding calcineurin-Crz1 signalling pathways and may find its application in the screening of antifungal agents. Abbreviations: Hsp: Hear shock protein; MIC: Minimum Inhibitory Concentration; SEM: Scanning Electron Microscopy; qRT-PCR: Quantitative Real-Time Polymerase Chain Reaction


10 July 2023 in Journal of Neurochemistry
Verified
Journal Article
Closed access
TSTulika Srivastava
Tulika Srivastava
DTDivya Tyagi
Divya Tyagi
SFSiraj Fatima
Siraj Fatima
MSMalur Thirumalesh Vishnu Sathyan
Malur Thirumalesh Vishnu Sathyan
RRRitu Raj
Ritu Raj
SPSmriti Priya
Smriti Priya